Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy - Hijazi, Z; Oldgren, J; Andersson, U (Circulation, 2012)
et al.